Femasys (NASDAQ:FEMY) Issues Earnings Results

Femasys (NASDAQ:FEMY) issued its quarterly earnings data on Friday. The company reported $0.00 EPS for the quarter, topping the consensus estimate of ($0.07) by $0.07, reports. Femasys had a negative net margin of 812.74% and a negative return on equity of 534.94%. The business had revenue of $0.42 million during the quarter, compared to analyst estimates of $0.77 million.

Femasys Stock Down 4.3%

NASDAQ FEMY traded down $0.02 during trading hours on Friday, reaching $0.43. 524,290 shares of the company’s stock traded hands, compared to its average volume of 412,557. Femasys has a 52-week low of $0.31 and a 52-week high of $1.14. The company has a debt-to-equity ratio of 0.89, a current ratio of 4.53 and a quick ratio of 2.95. The firm has a 50-day simple moving average of $0.47 and a 200 day simple moving average of $0.62. The firm has a market cap of $25.96 million, a PE ratio of -0.86 and a beta of -2.26.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on FEMY. Weiss Ratings raised shares of Femasys from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, May 1st. Lake Street Capital began coverage on Femasys in a research report on Tuesday, March 3rd. They set a “buy” rating and a $1.50 price objective on the stock. Finally, Wall Street Zen downgraded Femasys from a “hold” rating to a “sell” rating in a report on Saturday, March 28th. Four research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Femasys presently has a consensus rating of “Moderate Buy” and a consensus price target of $5.50.

Hedge Funds Weigh In On Femasys

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Jane Street Group LLC bought a new stake in shares of Femasys in the 4th quarter worth approximately $62,000. Banco BTG Pactual S.A. purchased a new stake in shares of Femasys in the 4th quarter worth approximately $88,000. Geode Capital Management LLC increased its position in Femasys by 50.8% during the 4th quarter. Geode Capital Management LLC now owns 389,280 shares of the company’s stock valued at $224,000 after buying an additional 131,052 shares in the last quarter. Cetera Investment Advisers purchased a new position in Femasys during the fourth quarter valued at $36,000. Finally, State Street Corp raised its stake in Femasys by 43.5% during the fourth quarter. State Street Corp now owns 80,869 shares of the company’s stock valued at $47,000 after buying an additional 24,500 shares during the last quarter. Institutional investors own 65.27% of the company’s stock.

About Femasys

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.